Answering reporters’ questions about #ENDO2025 while en route to San Francisco. Can’t wait to catch up with our endocrine community!

Getting in good trouble. #HandsOff2025 @indivisible.org

@alsobrooks.senate.gov Thank you for supporting Sen. Booker's speech and asking an important question about rising home costs. I appreciate you representing all of us in Maryland.

Rallying for the NIH and biomedical research! @standupforscience.bsky.social #StandUpForScience #InternationalWomensDay

I'm lucky to know lots of former and current dedicated public servants who want to ensure that our citizens are healthy, that our first responders have technologies to keep them safe, and that our electronic networks are secure, among other important work. I'm grateful for all you do. #FedLove

This is the most relevant article to NIH and research cuts I’ve seen. Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !” globalnews.ca/news/9793403...

So excited for @endocrinesociety.bsky.social Past President Dr. Teresa Woodruff, who received the National Medal of Science Friday for her pioneering work in oncofertility. bit.ly/4j2N1KI

@leotrasande.bsky.social discusses ways to protect ourselves from microplastics and endocrine-disrupting chemicals with @cnn.com's @drsanjaygupta.bsky.social. bit.ly/49s5LPb

New Medicare Advantage and Part D proposed rule is out. We are expanding access to anti-obesity medications, enhancing protections for people with Medicare against inappropriate use of prior authorization and misleading marketing, and increasing competition. Check it out: www.cms.gov/newsroom/fac...

There is a proposal for Medicare to pay for #GLP1 medications for obesity. Why wait until obesity-related diseases like #type2diabetes develop when you can prevent them from occurring in the first place? www.nytimes.com/2024/11/26/u...

Fellow communicators at health/science nonprofits in the DMV, we are restarting our networking lunch group from the pre-pandemic days. Message me if you are interested in connecting with other in-house PR and communications pros. Our first lunch will be Dec. 11. Looking forward to hearing from you!

Endocrine Society experts discuss the importance of prescribing FDA-approved medications to treat obesity. bit.ly/4hXc3dD

What to know about endocrine-disrupting chemicals, including PFAS, bisphenols and phthalates. Via Consumer Reports' @kevinloria.bsky.social. bit.ly/40XH5Mn

Opioid use has long-term effects on the endocrine system. MedCentral delves into the Endocrine Society's new Scientific Statement. bit.ly/3CuyG9c

Scientists' curiosity about gila monster venom led to breakthroughs in anti-obesity medications. Via @nytimes.com bit.ly/48R0YXs